Pain assessment and control are crucial aspects of palliative care, aimed at improving the quality of life of patients with serious advanced illnesses, particularly tumour diseases. Pain control is a priority in cancer care and requires multidisciplinary assessment and management. It is essential to tailor pain treatment to each patient’s individual needs, taking into account factors such as drug tolerance, co-morbidities and personal preferences. In this study, we attempted to assess cancer pain control and the prevalence of anxiety and depressive disorders in bronchopulmonary cancer, as well as their correlation with pain.